Posted inBusiness Amgen wins FDA nod for Lumakras as a drug combo for colorectal cancer Posted by admin January 17, 2025No Comments [ad_1] Amgen wins FDA nod for Lumakras as a drug combo for colorectal cancer [ad_2] admin View All Posts Post navigation Previous Post Schlumberger raises dividend by 3.6% to $0.285Next PostHuntington Bancshares Non-GAAP EPS of $0.34 beats by $0.02, revenue of $1.95B beats by $60M